Tamarack Advisers, LP Biomarin Pharmaceutical Inc Transaction History

Tamarack Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $6.5 Million - $7.52 Million	75,000 New	75,000 $6.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $3.37 Million - $3.97 Million	41,000 Added 136.67%	71,000 $6.02 Million
Q2 2022 Aug 16, 2022	BUY	$71.48 - $86.85 $2.14 Million - $2.61 Million	30,000 New	30,000 $2.49 Million
Q1 2022 May 11, 2022	SELL	$74.28 - $92.69 $6.69 Million - $8.34 Million	-90,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $6.45 Million - $8.23 Million	90,000 New	90,000 $7.95 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.